News
Learn more about whether Bitdeer Technologies Group or Vertex, Inc. is a better investment based on AAII's A+ Investor grades ...
Thirty-five states have agreed to participate in a federal pilot program aimed at helping Medicaid patients access costly ...
21h
Zacks Investment Research on MSNCRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?We expect investors to focus on the sales numbers of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other ...
The CHMP recommended granting a marketing authorization for Alyftrek, a medicine intended for the treatment of cystic fibrosis in people aged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results